In patients with LAL deficiency, treatment options include liver transplantation and hematopoietic stem cell (HSC) transplantation, which, however, have limited success in halting multiorgan lipid accumulation and disease progression (1). This evidence concerns the gene LIPA and hyperinsulinemic hypoglycemia, familial, 4.